Jianxin X. Guo

China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Prognostic and biological significance of MRPL13 in multiple myeloma: evidence from multi-cohort, single-cell analyses.

Prognostic and biological significance of MRPL13 in multiple myeloma: evidence from multi-cohort, single-cell analyses.

Journal: Frontiers in oncology

Published: May 13, 2026

Precision prediction of venetoclax-azacitidine treatment efficacy in acute myeloid leukemia via integrative drug screening and machine learning.

Precision prediction of venetoclax-azacitidine treatment efficacy in acute myeloid leukemia via integrative drug screening and machine learning.

Journal: Cell reports. Medicine

Published: April 03, 2025

Strongyloides stercoralis infection in a DLBCL patient treated with rituximab and BTK inhibitor: A case report and literature review.

Strongyloides stercoralis infection in a DLBCL patient treated with rituximab and BTK inhibitor: A case report and literature review.

Journal: Medicine

Published: February 24, 2025

Ancient genomes in Southwest China revealed genetic interactions among diverse populations in the historical period.

Ancient genomes in Southwest China revealed genetic interactions among diverse populations in the historical period.

Journal: BMC biology

Published: January 12, 2025

Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study

Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: May 08, 2024

A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy.

A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy.

Journal: Blood

Published: March 22, 2024

Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study.

Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: January 19, 2024

To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia

To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: December 04, 2023

The demic diffusion of Han culture into the Yunnan-Guizhou plateau inferred from ancient genomes.

The demic diffusion of Han culture into the Yunnan-Guizhou plateau inferred from ancient genomes.

Journal: National science review

Published: November 24, 2023

Protocol for a comprehensive pipeline to study ancient human genomes.

Protocol for a comprehensive pipeline to study ancient human genomes.

Journal: STAR protocols

Published: October 12, 2023

Ancient genomes reveal millet farming-related demic diffusion from the Yellow River into southwest China.

Ancient genomes reveal millet farming-related demic diffusion from the Yellow River into southwest China.

Journal: Current biology : CB

Published: May 31, 2023

Genomic formation of Tibeto-Burman speaking populations in Guizhou, Southwest China.

Genomic formation of Tibeto-Burman speaking populations in Guizhou, Southwest China.

Journal: BMC genomics

Published: May 27, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026